Educational and social inequalities and cause-specific mortality in Mexico City: a prospective study.


Journal

The Lancet. Public health
ISSN: 2468-2667
Titre abrégé: Lancet Public Health
Pays: England
ID NLM: 101699003

Informations de publication

Date de publication:
09 2023
Historique:
received: 24 02 2023
revised: 06 07 2023
accepted: 18 07 2023
medline: 28 8 2023
pubmed: 27 8 2023
entrez: 26 8 2023
Statut: ppublish

Résumé

Social inequalities in adult mortality have been reported across diverse populations, but there is no large-scale prospective evidence from Mexico. We aimed to quantify social, including educational, inequalities in mortality among adults in Mexico City. The Mexico City Prospective Study recruited 150 000 adults aged 35 years and older from two districts of Mexico City between 1998 and 2004. Participants were followed up until Jan 1, 2021 for cause-specific mortality. Cox regression analysis yielded rate ratios (RRs) for death at ages 35-74 years associated with education and examined, in exploratory analyses, the mediating effects of lifestyle and related risk factors. Among 143 478 participants aged 35-74 years, there was a strong inverse association of education with premature death. Compared with participants with tertiary education, after adjustment for age and sex, those with no education had about twice the mortality rate (RR 1·84; 95% CI 1·71-1·98), equivalent to approximately 6 years lower life expectancy, with an RR of 1·78 (1·67-1·90) among participants with incomplete primary, 1·62 (1·53-1·72) with complete primary, and 1·34 (1·25-1·42) with secondary education. Education was most strongly associated with death from renal disease and acute diabetic crises (RR 3·65; 95% CI 3·05-4·38 for no education vs tertiary education) and from infectious diseases (2·67; 2·00-3·56), but there was an apparent higher rate of death from all specific causes studied with lower education, with the exception of cancer for which there was little association. Lifestyle factors (ie, smoking, alcohol drinking, and leisure time physical activity) and related physiological correlates (ie, adiposity, diabetes, and blood pressure) accounted for about four-fifths of the association of education with premature mortality. In this Mexican population there were marked educational inequalities in premature adult mortality, which appeared to largely be accounted for by lifestyle and related risk factors. Effective interventions to reduce these risk factors could reduce inequalities and have a major impact on premature mortality. Wellcome Trust, the Mexican Health Ministry, the National Council of Science and Technology for Mexico, Cancer Research UK, British Heart Foundation, and the UK Medical Research Council Population Health Research Unit.

Sections du résumé

BACKGROUND
Social inequalities in adult mortality have been reported across diverse populations, but there is no large-scale prospective evidence from Mexico. We aimed to quantify social, including educational, inequalities in mortality among adults in Mexico City.
METHODS
The Mexico City Prospective Study recruited 150 000 adults aged 35 years and older from two districts of Mexico City between 1998 and 2004. Participants were followed up until Jan 1, 2021 for cause-specific mortality. Cox regression analysis yielded rate ratios (RRs) for death at ages 35-74 years associated with education and examined, in exploratory analyses, the mediating effects of lifestyle and related risk factors.
FINDINGS
Among 143 478 participants aged 35-74 years, there was a strong inverse association of education with premature death. Compared with participants with tertiary education, after adjustment for age and sex, those with no education had about twice the mortality rate (RR 1·84; 95% CI 1·71-1·98), equivalent to approximately 6 years lower life expectancy, with an RR of 1·78 (1·67-1·90) among participants with incomplete primary, 1·62 (1·53-1·72) with complete primary, and 1·34 (1·25-1·42) with secondary education. Education was most strongly associated with death from renal disease and acute diabetic crises (RR 3·65; 95% CI 3·05-4·38 for no education vs tertiary education) and from infectious diseases (2·67; 2·00-3·56), but there was an apparent higher rate of death from all specific causes studied with lower education, with the exception of cancer for which there was little association. Lifestyle factors (ie, smoking, alcohol drinking, and leisure time physical activity) and related physiological correlates (ie, adiposity, diabetes, and blood pressure) accounted for about four-fifths of the association of education with premature mortality.
INTERPRETATION
In this Mexican population there were marked educational inequalities in premature adult mortality, which appeared to largely be accounted for by lifestyle and related risk factors. Effective interventions to reduce these risk factors could reduce inequalities and have a major impact on premature mortality.
FUNDING
Wellcome Trust, the Mexican Health Ministry, the National Council of Science and Technology for Mexico, Cancer Research UK, British Heart Foundation, and the UK Medical Research Council Population Health Research Unit.

Identifiants

pubmed: 37633676
pii: S2468-2667(23)00153-6
doi: 10.1016/S2468-2667(23)00153-6
pmc: PMC7615266
mid: EMS181802
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e670-e679

Subventions

Organisme : Medical Research Council
ID : MC_UU_00017/2
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Références

Int J Epidemiol. 2021 Jul 9;50(3):955-964
pubmed: 33659992
Lancet Public Health. 2022 Nov;7(11):e923-e931
pubmed: 36334608
Lancet Planet Health. 2019 Dec;3(12):e503-e510
pubmed: 31836433
Diabetes Care. 2022 Dec 1;45(12):2957-2966
pubmed: 36286591
Lancet. 2005 Mar 19-25;365(9464):1099-104
pubmed: 15781105
Stat Med. 1991 Jul;10(7):1025-35
pubmed: 1652152
Ann Intern Med. 2019 Sep 17;171(6):397-405
pubmed: 31404923
JAMA Netw Open. 2020 Sep 1;3(9):e2018141
pubmed: 32975571
JAMA Intern Med. 2020 Sep 1;180(9):1185-1193
pubmed: 32897385
Int J Epidemiol. 2013 Aug;42(4):1012-4
pubmed: 24062287
PLoS Med. 2012 Feb;9(2):e1001179
pubmed: 22389633
BMC Public Health. 2011 Oct 07;11:771
pubmed: 21978183
JAMA. 2010 Mar 24;303(12):1159-66
pubmed: 20332401
N Engl J Med. 2016 Nov 17;375(20):1961-1971
pubmed: 27959614
BMC Public Health. 2018 Sep 10;18(1):1105
pubmed: 30200912
Health Aff (Millwood). 2016 Jan;35(1):88-95
pubmed: 26733705
Nicotine Tob Res. 2017 Nov 07;19(12):1401-1407
pubmed: 27679607
Salud Publica Mex. 2019 Sep-Oct;61(5):582-590
pubmed: 31661736
J Epidemiol Community Health. 2013 Feb;67(2):190-3
pubmed: 22875078
PLoS One. 2018 Jul 12;13(7):e0200501
pubmed: 30001429
Lancet. 2020 Mar 7;395(10226):795-808
pubmed: 31492503
SSM Popul Health. 2020 Aug 19;12:100649
pubmed: 32923576
Glob Public Health. 2010;5(4):413-26
pubmed: 19367478
BMJ Open. 2019 Aug 22;9(8):e026225
pubmed: 31444178
Prev Med. 2014 Jul;64:41-7
pubmed: 24674854
Int J Epidemiol. 2013 Aug;42(4):1018-22
pubmed: 24062290
Eur Heart J. 2008 Mar;29(6):800-9
pubmed: 18303034
Health Place. 2023 Mar;80:102998
pubmed: 36921377
Int J Epidemiol. 2006 Apr;35(2):243-9
pubmed: 16556648
Eur J Public Health. 2018 Apr 1;28(2):231-237
pubmed: 29020376
Int J Epidemiol. 2022 Dec 13;51(6):1711-1721
pubmed: 36174226
JAMA. 2020 Jan 28;323(4):309-310
pubmed: 31816035
Lancet Glob Health. 2017 Mar;5(3):e277-e289
pubmed: 28193397

Auteurs

Thomas Addey (T)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Jesus Alegre-Díaz (J)

Experimental Research Unit, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

Fiona Bragg (F)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Eirini Trichia (E)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Rachel Wade (R)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Rogelio Santacruz-Benitez (R)

Experimental Research Unit, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

Raúl Ramirez-Reyes (R)

Experimental Research Unit, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

Adrián Garcilazo-Ávila (A)

Experimental Research Unit, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

Carlos Gonzáles-Carballo (C)

Experimental Research Unit, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

Omar Yaxmehen Bello-Chavolla (OY)

Research Division, Instituto Nacional de Geriatría, Mexico City, Mexico.

Neftali Eduardo Antonio-Villa (NE)

Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.

Diego Aguilar-Ramirez (D)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Louisa Gnatiuc Friedrichs (LG)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Sarah Lewington (S)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Richard Peto (R)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Rory Collins (R)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Jaime Berumen (J)

Experimental Research Unit, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

Jonathan R Emberson (JR)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: jonathan.emberson@ndph.ox.ac.uk.

Pablo Kuri-Morales (P)

School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico; Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico.

Roberto Tapia-Conyer (R)

School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico. Electronic address: tapiaconyer@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH